Showing results (1031-1040 of 6,317) with videos related to
Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|November 17, 2025
Nomogram-based prediction of hypoglycemia risk in elderly community-dwelling patients with type 2 diabetes: Development and validation in a multicentre real-world cohortLingxue Chen, Li Wang, Adan Fu, et al.Diabetes, Obesity & Metabolism|November 10, 2025
Newly defined clinical obesity versus body mass index-defined obesity: Differential risks of overall death and adverse events in a population-based cohortLi-You Lian, Chuan Liu, Xiao-Dong Zhou, et al.Diabetes, Obesity & Metabolism|November 10, 2025
Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trialRui Sun, Ying Wang, Hongyan Shu, et al.Diabetes, Obesity & Metabolism|November 11, 2025
Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetesSean Wharton, Carel W le Roux, Biykem Bozkurt, et al.Diabetes, Obesity & Metabolism|November 21, 2025
Efficacy and safety of bi-weekly cofrogliptin treatment replacing daily dipeptidyl peptidase-4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open-label, randomized controlled phase 2 trialCongqing Pan, Hongwei Jiang, Yi Feng, et al.Diabetes, Obesity & Metabolism|January 12, 2026
Long-acting insulin analogues and the risk of diabetic nephropathy among patients with type 2 diabetes: A population-based cohort studyJulia Brillinger, Christopher Filliter, Shahrzad Salmasi, et al.Diabetes, Obesity & Metabolism|January 6, 2026
Associations between anthropometric measures of obesity and prediabetes risk: A dose-response meta-analysis of cohort studiesReza Amani-Beni, Bahar Darouei, Mohammadreza Mortaheb, et al.Diabetes, Obesity & Metabolism|January 9, 2026
Pharmacokinetic properties of insulin GZR4 after subcutaneous administration in the thigh, abdomen, or upper arm in healthy participantsLong Liu, Junmin Dong, Yuanxu Tong, et al.Diabetes, Obesity & Metabolism|January 14, 2026
Metformin attenuates metabolic insulin sensitivity and insulin-stimulated carbohydrate oxidation after high-intensity exercise training in adults at risk for metabolic syndromeSteven K Malin, Emily M Heiston, Daniel J Battillo, et al.Diabetes, Obesity & Metabolism|January 9, 2026
Long-term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: A 42-month follow-up of the J-MIND-Diabetes studyTaiki Sugimoto, Takuya Omura, Atsushi Araki, et al.Pageof 632